highly significantp<0.001
Combined-modality treatment, laboratory abnormality, stage and bone/liver metastases were highly significant survival predictors (p<0.001, <0.001, 0.001, 0.007 resp).
Combined-modality treatment, laboratory abnormality, stage and bone/liver metastases were highly significant survival predictors (p<0.001, <0.001, 0.001, 0.007 resp).
On further analysis grade I tumours, lymph node-negative tumours, patients with <3 positive lymph nodes and ER/PR positive tumours showed a definite trend to have only unmethylated alleles i.e. active p16.
In contrast, the Ki-67 index was higher for the SCC subgroup, although this difference did not reach statistical significance.